Neurotrack is just one of various approaches researchers are exploring as cheap, easy measures of presymptomatic Alzheimer's. (scientificamerican.com)
Blood tests, retinal scans and computerized cognitive tests are also in the running as simple screens for presymptomatic Alzheimer's. (scientificamerican.com)
In other studies ongoing at CUIMC, solanezumab is being evaluated in presymptomatic patients at risk of Alzheimer's disease. (sciencedaily.com)